Visterra
AcquiredBringing better biologics to life.
Cambridge, United States · Founded 2007 · $116.1M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- visterra.com
- Total Funding
- $116.1M
- Last Round
- $23.6M Series COct 2017
- Rounds
- 7
- Acquisition Date
- Jul 2018
About
Visterra is a biologics research and early-stage clinical development company focused on developing novel therapeutics for patients with immune-mediated and other hard-to-treat diseases. The company applies cutting-edge computational, AI, and experimental research methods alongside agile preclinical development to engineer next-generation antibody-based therapies. Visterra's lead program, sibeprenlimab (VIS171), targets IgA nephropathy (IgAN) and has received FDA acceptance and Priority Review designation. The company leverages a unique platform combining structural biology, computational design, and proprietary antibody engineering to develop differentiated biologics. Originally spun out of MIT, Visterra was founded in 2007 and is based in Cambridge, Massachusetts. The company was acquired by Otsuka Holdings, which continues to advance its clinical pipeline.
Summary
Visterra is a Biotech company based in Cambridge, United States, founded in 2007. It has raised $116.1M in total across 7 rounds, most recently a $23.6M Series C round in Oct 2017. Investors include Otsuka Pharmaceutical, Polaris Partners and Vertex Venture Holdings.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2018
Sign up to see all 8 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/visterra"><img src="https://indexed.vc/api/badge/company/visterra" alt="Visterra on Indexed.vc" width="260" height="76" /></a>